Associate Director, Clinical Operations Study Lead (COSL)
BlueRock Therapeutics Apply for this positionAbout this role
Who is BlueRock?
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
What Are We Doing?
Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.
We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.
We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients’ lives.
The Clinical Operations Study Lead (COSL)/Associate Director oversees the management and operations of one or more BlueRock clinical trials. The individual in this role is the accountable BlueRock leader for the operational planning, execution, and oversight of clinical studies. In this role, the COSL ensures that studies are conducted in alignment with regulatory requirements, and timelines, while fostering a culture of cross-functional collaboration and operational excellence.
About BlueRock Therapeutics
Cell therapy subsidiary of Bayer developing engineered iPSC-derived therapies for neurology and cardiology. Based in Cambridge, MA.